Literature DB >> 8544909

Constitutive Alzheimer's-type tau epitopes in a neuritogenic rat CNS cell line.

M P Lambert1, S Sabo, C Zhang, S A Enam, W L Klein.   

Abstract

Paired helical filaments (PHFs) of Alzheimer's disease (AD) largely comprise hyperphosphorylated forms of the cytoskeletal protein tau. AD-type tau phosphoepitopes, detected by various monoclonal antibodies, are absent from normal adult neurons, but recent studies have shown that their expression may contribute to neuritogenesis and axon differentiation in the developing nervous system. Therefore, we have examined a brain nerve cell line that is spontaneously neuritogenic for possible expression of AD-type tau epitopes. The neuritogenic rat brain cell line B103 was found to constitutively produce two-AD related epitopes of tau, detected by cellular immunofluorescence studies with the PHF-1 and Alz-50 monoclonal antibodies. Biochemical studies showed that the antibodies bound to proteins within the molecular, weight range expected for phosphorylated tau isoforms. Further verification was established by use of tau antisense oligomers, which eliminated cellular immunofluorescence due to the AD-related monoclonals and polyclonal anti-tau but did not eliminate fluorescence due to anti-tubulin. Cells treated with tau antisense were not neurite-free. Neurites that remained, however, were abnormal, generally short and wavy in appearance. Cellular distribution of the tau epitopes was found to be particularly interesting. Alz-50 recognized only cytoplasmic tau whereas PHF-1 recognized nuclear tau as well as cytoplasmic. Thus, the two epitopes, are morphologically segregated within the cell. Because subcellular segregation of tau is compromised in Alzheimer's disease, mechanisms that segregate AD-type phosphotau epitopes in B103 cells may have relevance to this neurodegenerative disorder.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544909     DOI: 10.1016/0197-4580(95)00042-d

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

Review 1.  Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.

Authors:  Gerhard Multhaup; Otmar Huber; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2015-08-21       Impact factor: 5.157

2.  Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice.

Authors:  H L Melrose; J C Dächsel; B Behrouz; S J Lincoln; M Yue; K M Hinkle; C B Kent; E Korvatska; J P Taylor; L Witten; Y-Q Liang; J E Beevers; M Boules; B N Dugger; V A Serna; A Gaukhman; X Yu; M Castanedes-Casey; A T Braithwaite; S Ogholikhan; N Yu; D Bass; G Tyndall; G D Schellenberg; D W Dickson; C Janus; M J Farrer
Journal:  Neurobiol Dis       Date:  2010-07-24       Impact factor: 5.996

Review 3.  Variations in brain DNA.

Authors:  Jesús Avila; Alberto Gómez-Ramos; Eduardo Soriano
Journal:  Front Aging Neurosci       Date:  2014-11-25       Impact factor: 5.750

4.  Thermodynamics of the interaction between Alzheimer's disease related tau protein and DNA.

Authors:  Sergio Camero; María J Benítez; Raquel Cuadros; Félix Hernández; Jesús Avila; Juan S Jiménez
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

Review 5.  Nuclear Tau and Its Potential Role in Alzheimer's Disease.

Authors:  Mahmoud Bukar Maina; Youssra K Al-Hilaly; Louise C Serpell
Journal:  Biomolecules       Date:  2016-01-07

6.  Phosphorylation of nuclear Tau is modulated by distinct cellular pathways.

Authors:  Giorgio Ulrich; Agnese Salvadè; Paul Boersema; Tito Calì; Chiara Foglieni; Martina Sola; Paola Picotti; Stéphanie Papin; Paolo Paganetti
Journal:  Sci Rep       Date:  2018-12-07       Impact factor: 4.379

7.  Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer's disease.

Authors:  Xuting Xu; Yunliang Wang; Lingyan Wang; Qi Liao; Lan Chang; Leiting Xu; Yi Huang; Huadan Ye; Limin Xu; Cheng Chen; Xiaowei Shen; Fuqiang Zhang; Meng Ye; Qinwen Wang; Shiwei Duan
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.